Endo Axing 90 Employees in Restructuring – Genetic Engineering & Biotechnology News
Endo International said today it will eliminate 90 full-time positions in a restructuring designed to lower costs, increase efficiencyand bring the company back into the black following recent losses and a plunge in its stock price. Endo said its restructuring would primarily affect its corporate and branded pharmaceutical R&D operations at its U.S. headquarters in…